Total healthcare costs were significantly lower among adults with diabetes who used continuous glucose monitoring (CGM) systems compared to those who did not use CGM, according to a December study ...

Frequent CGM use ties to bigger A1c drops in type 2 diabetes, even across GLP-1, SGLT2, and insulin regimens. In this episode ...

The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...

Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the ...

Continuous glucose monitors (CGMs) have transformed diabetes management by delivering real-time insight into glucose trends without the need for frequent finger-stick testing. As these devices ...

Senseonics is bringing the commercialization and distribution of its continuous glucose monitor products back in-house. The Germantown, MD-based company said it has signed a Memorandum of ...

Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one ...